← FDA DRUG APPROVALS

FDA ANDA · ANDA089166

SYNALGOS-DC-A

Sponsor: LEITNER PHARMS

APPLICATION
ANDA089166
TYPE
ANDA
ORIGINAL APPROVAL
1986-05-14
LATEST ACTION
1986-10-27
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

SYNALGOS-DC-ADiscontinued
ACETAMINOPHEN 356.4MG, CAFFEINE 30MG, DIHYDROCODEINE BITARTRATE 16MG · CAPSULE · ORAL

Approval history

1986-10-27Manufacturing (CMC) · Supplement 1AP
1986-09-10Manufacturing (CMC) · Supplement 2AP
1986-05-14OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →